11 months ago
Nature Communications | Chinese Medical Team Innovates CAR-T Therapy to Bring New Hope for AML Treatment AML In the field of hematological malignancies, the treatment of acute myeloid leukemia (AML...
11 months ago
Tecartus All Approval Tecartus (brexucabtagene autoleucel) has emerged as a revolutionary CAR-T cell therapy, gaining approval from the U.S. Food and Drug Administration (FDA) for the treatment of ...
11 months ago
**Chinese Medical Team Research: 64.6% Complete Remission Rate, Over Half of Patients Progression-Free for More Than Two Years! Targeted Therapy Combined with Chemotherapy is Safe and Effective as...
11 months ago
### Overcoming Challenges and Embracing New Life! – Breakthrough Progress of Eque-cel in the Treatment of Refractory Multiple Myeloma Multiple Myeloma In the treatment of multiple myeloma (...
11 months ago
### Gratitude to the Doctors and Nurses at Jiahui International Hospital in Shanghai: After undergoing the processes of apheresis and reinfusion, Teresa feels immense gratitude towards the doctors...
11 months ago
感谢上海嘉会国际医院的医生护士： 在经历了单采，回输等过程后，Teresa对上海嘉会国际医院的医生和护士们心怀感激。她深深体会到了医护人员的专业和关怀。 在Dr. Vicky Lee及其团队的指导下，整个采集输注过程...
11 months ago
T Cell Lymphoma Stem Cell Transplant The 29th Annual Congress of the European Hematology Association (EHA) will be held from June 13-16, 2024, in Madrid, Spain, in a hybrid format combining virtual...
11 months ago
Stem Cell Evidence Found for Treating Premature Ovarian Failure! Successful Stem Cell Transplants in 35 Patients in China Help Women Pause Aging Stem Cell As women age, not only does their appearan...
11 months ago
T Cell Lymphoma CAR-T Therapy Achieves Complete Remission in 28 Days In early June 2024, the results of a Phase I clinical trial for the CD7-CAR-T product PA3-17 in the treatment of relapsed/refrac...
11 months ago
Price of Yescarta(Axicabtagene ciloleucel) The initial list price for Yescarta was set at approximately $373,000 per treatment. This cost covers the complex manufacturing process, which involves co...
11 months ago
Price of Kymriah Kymriah is a gene therapy treatment developed by Novartis Pharmaceuticals for certain types of blood cancers. It works by reprogramming the patient’s T cells to target and de...
11 months ago
**Chinese Medical Team: Long Survival and Significant Benefits with BCMA CAR-T Treatment for RRMM: A 5-Year Outlook** RRMM Chimeric antigen receptor (CAR) T-cell therapy is one of the most promis...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
